Neko Health confirms billion-dollar valuation ahead of US expansion
Daniel Ek's health tech company, Neko Health, has confirmed a new capital round that quadruples its valuation to SEK 6.7 billion. This makes the company Sweden's highest-valued unlisted tech firm.
What happened?
Neko Health, co-founded by Daniel Ek, has completed a capital round resulting in a valuation of SEK 6.7 billion. The company is planning an expansion into the US, which serves as the primary driver for the new financing. This valuation represents a nearly fourfold increase from previous funding rounds.
Key facts
| Värdering | 6,7 miljarder SEK |
|---|---|
| Expansion | USA |
| Typ av bolag | Hälsoteknik |
”Daniel Eks hälsobolag nu in en jätterunda, som skjuter upp värderingen med nästan fyra gånger till 67 miljarder kronor.”
”I och med det blir Neko Health Sveriges högst värderade teknikbolag utanför börsen.”
Why it matters
The valuation surge positions Neko Health as a prominent player in the health technology sector. Expansion into the American market marks a significant step for the company, with potential implications for how preventative healthcare is delivered and scaled globally. This success may also influence the investment climate for Swedish tech companies.
Who is affected?
The capital round primarily affects Neko Health and its investors. Indirectly, it impacts the Swedish tech scene as the company now holds the title of Sweden's highest-valued unlisted technology firm. In the long term, consumers in the US and potentially other markets may be affected as Neko Health's services become available there.
What else you should know
This valuation places Neko Health at the top of Swedish unlisted tech companies, a position historically held by companies such as Northvolt and Klarna at similar stages of development.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Vilka bolag berörs?
The link opens in a new window and leads to the publisher's own site.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.
AI-verktyg i artikeln
Topics
Get similar news straight to your inbox
The reader's room
Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.
Sign in to submit a comment or question.
Read the article through your role
- Where does a window open: market, tech, distribution or pricing?
- What can you test in under two weeks without burning capital?
- Who do you need to talk to this week to validate the assumption?
Generated angle — not editorial analysis of "Neko Health confirms billion-dollar valuation ahead of US ex"